Klinikum Bremen-Ost

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Alzheimer disease1 trial
• Mesothelioma1 trial
• Mild cognitive impairment1 trial

Phase

• Phase 41 trial

Status

• Recruiting2 trials
• Active, not recruiting1 trial

Lead sponsor

• NovoCure Ltd.1 trial
• RWTH Aachen University1 trial
• Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR1 trial

Running trials

• Recruiting

  TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study

  NCT05538806· NovoCure Ltd.· Source

  Contact: André Bethge

• Active, not recruiting

  AFAMOSI: Prospective, randomized, multicenter Phase IV study to evaluate the efficacy and safety of afatinib followed by osimertinib compared to osimertinib in patients with EGFRmutated/T790M Mutation negative non-squamous NSCLC in the first-line setting

  NCT04413201· Phase 4· Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR· Source

• Recruiting

  German Dementia Registry

  NCT07433010· RWTH Aachen University· Source

  Contact: Prof. Dr. Jörg B. Schulz, MD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease1 recruiting
• Lung cancer1 recruiting
• Mesothelioma1 recruiting
• Mild cognitive impairment1 recruiting